TheraJect
Mr. Shah was the senior vice president of Noveon, Inc., formerly the specialty chemicals business of BFGoodrich. During this three-year period, Mr. Shah was responsible for making 12 acquisitions that contributed 20% of the $600 million shareholder value created. Noveon was acquired by Lubrizol in June 2004 in a $2 billion transaction that Mr. Shah negotiated. Mr. Shah was the senior vice president in charge of corporate development at International Specialty Products, Cytec Industries Inc. and American Cyanamid Company. He is a chemical engineer and graduated with honors from the Indian Institute of Technology, Bombay and also has graduate degrees from the Polytechnic Institute of Brooklyn (MS, Polymeric Materials) and New York University School of Business Administration (MBA, Finance) .
This person is not in the org chart
This person is not in any teams
This person is not in any offices